James B Breitmeyer Oncternal Therapeutics, Inc. (ONCT) insider trading activity

ONCT Quotes by TradingView

JAMES B BREITMEYER Transaction History

Date Transaction Value Shares Traded Form
Jan 03 2024
SELL
Payment of exercise price or tax liability
$2,242 $0.5 p/Share
4,485
Jul 03 2023
SELL
Payment of exercise price or tax liability
$1,442 $0.36 p/Share
4,007
Apr 14 2023
BUY
Open market or private purchase
$15,000 $0.3 p/Share
50,000
Apr 13 2023
BUY
Open market or private purchase
$28,999 $0.29 p/Share
100,000
Jan 03 2023
SELL
Payment of exercise price or tax liability
$1,351 $1.02 p/Share
1,325
Jul 28 2022
BUY
Grant, award, or other acquisition
-
18,750
Jan 27 2022
BUY
Open market or private purchase
$42,000 $1.68 p/Share
25,000
Jan 03 2022
BUY
Grant, award, or other acquisition
-
6,793

Also insider at

OTIC
OTONOMY, INC. Healthcare
Director
ZGNX
ZOGENIX, INC.
Director
JBB

James B Breitmeyer

Chief Executive Officer
San Diego, CA

Track Institutional and Insider Activities on ONCT

Follow Oncternal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONCT shares.

Notify only if

Insider Trading

Get notified when an Oncternal Therapeutics, Inc. insider buys or sells ONCT shares.

Notify only if

News

Receive news related to Oncternal Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONCT